Notice for burosumab (Kyowa Kirin Australia Pty Ltd)
Active ingredients
burosumab
Sponsor
Date of review outcome
Lapse date
Type
Orphan drug
Dosage form(s)
Solution for subcutaneous Injection
Indication
Treatment of X-linked hypophosphataemia (XLH)
Therapeutic area
Endocrinology